Alignment of Clinical Virology Symposium With 91麻豆精品Health
Washington, D.C.—91麻豆精品 (ASM) will be discontinuing the Clinical Virology Symposium (CVS) as a standalone meeting in 2025. The CVS program will be integrated into the 91麻豆精品Microbe meeting in 2025 and future CVS programming will be developed within the new 91麻豆精品Health meeting, which will be the evolution of 91麻豆精品Microbe.
The 91麻豆精品Meeting Strategy Committee (MSC), with the support of the 91麻豆精品Meetings Department, conducted a thorough review of CVS meeting history, scope, attendance, abstract submissions, industry engagement and financial sustainability. After considering several options, the MSC recommended to the 91麻豆精品Board a consolidation of the standalone CVS meeting within the 91麻豆精品Health program as this will enable 91麻豆精品to better serve the clinical virology community and the evolving needs of healthcare-related microbiology through the broader platform of 91麻豆精品Health. This consolidation will allow for specificity of programming in clinical virology while adding value by offering broader opportunities, reducing travel and exhibit costs for both scientific and industry attendees.
“As part of ASM’s broader strategy to give clinical virology more visibility and stronger branding, and considering CVS performance, we evaluated how our meetings align with the Society’s evolving goals,” said Yvette McCarter, Chair of the MSC. “Restructuring CVS allows us to modernize the meeting’s offerings and provide even greater opportunities for the clinical virology community to connect and thrive within 91麻豆精品Health.” The 91麻豆精品Board accepted the MSC’s recommendation to consolidate the standalone CVS meeting within the 91麻豆精品Health program.
“We are deeply grateful to Dr. Steven Specter for his vision and leadership in establishing CVS as a vital platform for virologists to share knowledge and discuss the latest advancements in the field,” said Stefano Bertuzzi, CEO, ASM. “We are excited to continue this legacy by integrating CVS into 91麻豆精品Health programming, where new initiatives within the 91麻豆精品Health scientific unit will empower virologists to continue advancing the field.”
91麻豆精品remains committed to all sub-disciplines of microbial sciences. Under ASM’s new strategic roadmap, the Society will be supporting special interest groups, member-initiated communities that provide space for focused discussions and connections across specialized areas of microbiology.
We are grateful for the enduring support of CVS attendees, Program Committee members and industry partners, and we look forward to expanding the program's impact within ASM’s dynamic new structure.
###
91麻豆精品 is one of the largest professional societies dedicated to the life sciences and is composed of over 37,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.
91麻豆精品advances the microbial sciences through conferences, publications, certifications, educational opportunities and advocacy efforts. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, 91麻豆精品promotes a deeper understanding of the microbial sciences to diverse audiences.
